{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:12:34Z","timestamp":1779189154449,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:00:00Z","timestamp":1477526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:00:00Z","timestamp":1477526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["TS110036"],"award-info":[{"award-number":["TS110036"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00262-016-1920-8","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T14:23:07Z","timestamp":1477578187000},"page":"63-75","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice"],"prefix":"10.1007","volume":"66","author":[{"given":"Jonathan M.","family":"Eby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levi","family":"Barse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Henning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn J. W. E.","family":"Rabelink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Klarquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily R.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M.","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel F.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah G.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward R.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Garrett-Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Dilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob C.","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Caroline","family":"Le Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,27]]},"reference":[{"key":"1920_CR1","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4161\/auto.27959","volume":"10","author":"P Matarrese","year":"2014","unstructured":"Matarrese P, Garofalo T, Manganelli V, Gambardella L, Marconi M, Grasso M, Tinari A, Misasi R, Malorni W, Sorice M (2014) Evidence for the involvement of GD3 ganglioside in autophagosome formation and maturation. Autophagy 10:750\u2013765. doi:10.4161\/auto.27959","journal-title":"Autophagy"},{"key":"1920_CR2","doi-asserted-by":"publisher","first-page":"40410","DOI":"10.1074\/jbc.M207117200","volume":"277","author":"XQ Wang","year":"2002","unstructured":"Wang XQ, Sun P, Paller AS (2002) Ganglioside modulation regulates epithelial cell adhesion and spreading via ganglioside-specific effects on signaling. J Biol Chem 277:40410\u201340419","journal-title":"J Biol Chem"},{"key":"1920_CR3","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.0800126","volume":"182","author":"S Motohashi","year":"2009","unstructured":"Motohashi S, Nagoto K, Kunii N, Yamamoto H, Yamasaki K, Okita K, Hanaoka H, Shimizu N, Suzuki M, Yoshino I, Tanaguchi M, Fujisawa T, Nakayama T (2009) A phase I\u2013II study of alpha-galactosylceramide-pulsed IL-2\/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J Immunol 182:2492\u20132501. doi:10.4049\/jimmunol.0800126","journal-title":"J Immunol"},{"key":"1920_CR4","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.febslet.2012.05.041","volume":"586","author":"W Spessott","year":"2012","unstructured":"Spessott W, Crespo PM, Daniotti JL, Maccioni HJ (2012) Glycosyltransferase complexes improve glycolipid synthesis. FEBS Lett 586:2346\u20132350. doi:10.1016\/j.febslet.2012.05.041","journal-title":"FEBS Lett"},{"key":"1920_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/(SICI)1097-4547(19991015)58:2<318::AID-JNR12>3.0.CO;2-U","volume":"58","author":"JL Daniotti","year":"1999","unstructured":"Daniotti JL, Martina JA, Zurita AR, Maccioni HJ (1999) Mouse beta 1,3-galactosyltransferase (GA1\/GM1\/GD1b synthase): protein characterization, tissue expression, and developmental regulation in neural retina. J Neurosci Res 58:318\u2013327","journal-title":"J Neurosci Res"},{"key":"1920_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000111565","volume":"16","author":"T Ariga","year":"2008","unstructured":"Ariga T, Suetake K, Nakane M, Kubota M, Usuki S, Kawashima I, Yu RK (2008) Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors. Neurosignals 16:226\u2013234. doi:10.1159\/000111565","journal-title":"Neurosignals"},{"key":"1920_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ajpath.2013.04.002","volume":"183","author":"ER Gilbert","year":"2013","unstructured":"Gilbert ER, Eby JM, Hammer AM, Klarquist J, Christensen DG, Barfuss AJ, Boissy RE, Picken MM, Love RB, Dilling DF, Le Poole IC (2013) Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis. Am J Pathol 183:226\u2013234. doi:10.1016\/j.ajpath.2013.04.002","journal-title":"Am J Pathol"},{"key":"1920_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0300-9084(03)00006-3","volume":"85","author":"S Birkl\u00e9","year":"2003","unstructured":"Birkl\u00e9 S, Zeng G, Gao L, Yu RK, Aubry J (2003) Role of tumor-associated gangliosides in cancer progression. Biochimie 85:455\u2013463","journal-title":"Biochimie"},{"key":"1920_CR9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1096\/fj.04-1675fje","volume":"18","author":"B Tomassini","year":"2004","unstructured":"Tomassini B, Malisan F, Franchi L, Nicol\u00f2 C, Calvo GB, Saito T, Testi R (2004) Calnexin suppresses GD3 synthase-induced apoptosis. FASEB J 18:1553\u20131555","journal-title":"FASEB J"},{"key":"1920_CR10","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1074\/jbc.M512379200","volume":"281","author":"HY Chen","year":"2006","unstructured":"Chen HY, Challa AK, Varki A (2006) 9-O-acetylation of exogenously added ganglioside GD3. The GD3 molecule induces its own O-acetylation machinery. J Biol Chem 281:7825\u20137833","journal-title":"J Biol Chem"},{"key":"1920_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0042-6989(01)00185-7","volume":"42","author":"JW Streilein","year":"2002","unstructured":"Streilein JW, Ma N, Wenkel H, Ng TF, Zamiri P (2002) Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res 42:487\u2013495","journal-title":"Vision Res"},{"key":"1920_CR12","first-page":"383","volume":"288","author":"AN Houghton","year":"1989","unstructured":"Houghton AN, Bajorin DF, Lonberg M, Chapman P (1989) Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside. Prog Clin Biol Res 288:383\u2013390","journal-title":"Prog Clin Biol Res"},{"key":"1920_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1517\/13543784.2013.750293","volume":"22","author":"J Zhan","year":"2013","unstructured":"Zhan J, Han Q, Wang K (2013) Development of antibody therapeutics for small cell lung cancer. Expert Opin Investig Drugs 22:235\u2013244. doi:10.1517\/13543784.2013.750293","journal-title":"Expert Opin Investig Drugs"},{"key":"1920_CR14","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.ejca.2008.06.036","volume":"44","author":"A Bottomley","year":"2008","unstructured":"Bottomley A, Debruyne C, Felip E, Millward M, Thiberville L, D\u2019Addario G, Rome L, Zatloukal P, Coens C, Giaccone G (2008) Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2\/BCG in responding patients with limited disease small-cell lung cancer. Eur J Cancer 44:2178\u20132184. doi:10.1016\/j.ejca.2008.06.036","journal-title":"Eur J Cancer"},{"key":"1920_CR15","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3324\/haematol.2013.084640","volume":"99","author":"GT Stevenson","year":"2014","unstructured":"Stevenson GT (2014) Three major uncertainties in the antibody therapy of cancer. Haematologica 99:1538\u20131546. doi:10.3324\/haematol.2013.084640","journal-title":"Haematologica"},{"key":"1920_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"Byers LA, Rudin CM (2015) Small cell lung cancer: where do we go from here? Cancer 121:664\u2013672. doi:10.1002\/cncr.29098","journal-title":"Cancer"},{"key":"1920_CR17","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-10-0043","volume":"16","author":"AS Lo","year":"2010","unstructured":"Lo AS, Ma Q, Liu DL, Junghans RP (2010) Anti-GD3 chimeric sFv-CD28\/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors. Clin Cancer Res 16:2769\u20132780. doi:10.1158\/1078-0432.CCR-10-0043","journal-title":"Clin Cancer Res"},{"key":"1920_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fimmu.2014.00543","volume":"5","author":"FC Robertson","year":"2014","unstructured":"Robertson FC, Berzofsky JA, Terabe M (2014) NKT cell networks in the regulation of tumor immunity. Front Immunol 5:543. doi:10.3389\/fimmu.2014.00543","journal-title":"Front Immunol"},{"key":"1920_CR19","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.4049\/jimmunol.1001018","volume":"185","author":"G Wingender","year":"2010","unstructured":"Wingender G, Krebs P, Beutler B, Kronenberg M (2010) Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95\/CD178-dependent and is correlated with antigenic potency. J Immunol 185:2721\u20132729. doi:10.4049\/jimmunol.1001018","journal-title":"J Immunol"},{"key":"1920_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2567.2007.02760.x","volume":"123","author":"JE Park","year":"2008","unstructured":"Park JE, Wu DY, Lu SX, Raghupathi G, Schrantz N, Chapman PB (2008) Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand. Immunology 123:145\u2013155","journal-title":"Immunology"},{"key":"1920_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0065-230X(08)00408-9","volume":"101","author":"M Terabe","year":"2008","unstructured":"Terabe M, Berzofsky JA (2008) The role of NKT cells in tumor immunity. Adv Cancer Res 101:277\u2013348. doi:10.1016\/S0065-230X(08)00408-9","journal-title":"Adv Cancer Res"},{"key":"1920_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/jclinpath-2014-202735","volume":"68","author":"TW Chong","year":"2015","unstructured":"Chong TW, Goh FY, Sim MY, Huang HH, Thike DA, Lim WK, The BT, Tan PH (2015) CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival. J Clin Pathol 68:200\u2013205. doi:10.1136\/jclinpath-2014-202735","journal-title":"J Clin Pathol"},{"key":"1920_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ijc.10141","volume":"98","author":"T Fiedler","year":"2002","unstructured":"Fiedler T, Walter W, Reichert TE, Maeurer MJ (2002) Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules? Int J Cancer 98:389\u2013397","journal-title":"Int J Cancer"},{"key":"1920_CR24","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1073\/pnas.1300200110","volume":"110","author":"X Wen","year":"2013","unstructured":"Wen X, Rao P, Carre\u00f1o LJ, Kim S, Lawrenczyk A, Porcelli SA, Cresswell P, Yuan W (2013) Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells. Proc Natl Acad Sci U S A 110:2963\u20132968. doi:10.1073\/pnas.1300200110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1920_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/eji.200323707","volume":"33","author":"JK Sandberg","year":"2003","unstructured":"Sandberg JK, Bhardwaj N, Nixon DF (2003) Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur J Immunol 33:588\u2013596","journal-title":"Eur J Immunol"},{"key":"1920_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00002371-200405000-00003","volume":"27","author":"L Schumacher","year":"2004","unstructured":"Schumacher L, Ribas A, Dissette VB, McBride WH, Mukherji B, Economou JS, Butterfield LH (2004) Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses. J Immunother 27:191\u2013200","journal-title":"J Immunother"},{"key":"1920_CR27","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/21645515.2015.1016674","volume":"11","author":"K Xiang","year":"2015","unstructured":"Xiang K, Ying G, Yan Z, Shanshan Y, Lei Z, Hongjun L, Maosheng S (2015) Progress on adenovirus-vectored universal influenza vaccines. Hum Vaccin Immunother 11:1209\u20131222. doi:10.1080\/21645515.2015.1016674","journal-title":"Hum Vaccin Immunother"},{"key":"1920_CR28","doi-asserted-by":"publisher","first-page":"e94050","DOI":"10.1371\/journal.pone.0094050","volume":"9","author":"Q Gao","year":"2014","unstructured":"Gao Q, Chen C, Ji T, Wu P, Han Z, Fang H, Li F, Liu Y, Hu W, Gong D, Zhang Z, Wang S, Zhou J, Ma D (2014) A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKs. PLoS ONE 9:e94050. doi:10.1371\/journal.pone.0094050","journal-title":"PLoS ONE"},{"key":"1920_CR29","doi-asserted-by":"crossref","unstructured":"Mosenson JA, Zloza A, Nieland JD, Garrett-Mayer E, Eby JM, Huelsmann EJ, Kumar P, Denman CJ, Lacek AT, Kohlhapp FJ, Alamiri A, Hughes T, Bines SD, Kaufman HL, Overbeck A, Mehrotra S, Hernandez C, Nishimura MI, Guevara-Patino JA, Le Poole IC (2013) Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013 Feb 27;5(174):174ra28. doi: 0.1126\/scitranslmed.3005127","DOI":"10.1126\/scitranslmed.3005127"},{"key":"1920_CR30","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1172\/JCI25591","volume":"116","author":"JA Guevara-Pati\u00f1o","year":"2006","unstructured":"Guevara-Pati\u00f1o JA, Engelhorn ME, Turk MJ, Liu C, Duan F, Rizzuto G, Cohen AD, Merghoub T, Wolchok JD, Houghton AN (2006) Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J Clin Invest 116:1382\u20131390","journal-title":"J Clin Invest"},{"key":"1920_CR31","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/jid.2008.45","volume":"128","author":"CJ Denman","year":"2008","unstructured":"Denman CJ, McCracken J, Hariharan V, Klarquist J, Oyarbide-Valencia K, Guevara-Pati\u00f1o JA, Le Poole IC (2008) HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. J Invest Dermatol 128:2041\u20132048. doi:10.1038\/jid.2008.45","journal-title":"J Invest Dermatol"},{"key":"1920_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","volume":"7","author":"FJ Fallaux","year":"1996","unstructured":"Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC, Van Der Eb AJ (1996) Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7:215\u2013222","journal-title":"Hum Gene Ther"},{"key":"1920_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MM Tomayko","year":"1989","unstructured":"Tomayko MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24:148\u2013154","journal-title":"Cancer Chemother Pharmacol"},{"key":"1920_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u2206\u2206CT method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"1920_CR35","volume-title":"Biometry: the principles and practices of statistics in biological research","author":"RR Sokal","year":"1994","unstructured":"Sokal RR, Rohlf FJ (1994) Biometry: the principles and practices of statistics in biological research, 3rd edn. W.H. Freeman and Company, New York","edition":"3"},{"key":"1920_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1165\/rcmb.2011-0215TR","volume":"46","author":"DF Dilling","year":"2012","unstructured":"Dilling DF, Gilbert ER, Picken MM, Eby JM, Love RB, Le Poole IC (2012) A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment options. Am J Respir Cell Mol Biol 46:1\u20135. doi:10.1165\/rcmb.2011-0215TR","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1920_CR37","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1158\/0008-5472.CAN-10-4108","volume":"71","author":"Y Yamauchi","year":"2011","unstructured":"Yamauchi Y, Furukawa K, Hamamura K, Furukawa K (2011) Postive feedback loop between PI3K-Akt-mTORC1 signalling and the lipogenic pathway boost Akt signaling: induction of the lipogenic pathway by a melanoma antigen. Cancer Res 71:4989\u20134997. doi:10.1158\/0008-5472.CAN-10-4108","journal-title":"Cancer Res"},{"key":"1920_CR38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1046\/j.1471-4159.1999.0720514.x","volume":"72","author":"S Ruan","year":"1999","unstructured":"Ruan S, Raj BK, Lloyd KO (1999) Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells. J Neurochem 72:514\u2013521","journal-title":"J Neurochem"},{"key":"1920_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00432-008-0536-6","volume":"135","author":"E Ruckh\u00e4berle","year":"2009","unstructured":"Ruckh\u00e4berle E, Karn T, Rody A, Hanker L, G\u00e4tje R, Metzler D, Holtrich U, Kaufmann M (2009) Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer. J Cancer Res Clin Oncol 135:1005\u20131013. doi:10.1007\/s00432-008-0536-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"1920_CR40","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1158\/0008-5472.CAN-11-2695","volume":"72","author":"TJ Webb","year":"2012","unstructured":"Webb TJ, Li X, Giuntoli RL, Lopez PH, Heuser C, Schnaar RL, Tsuji M, Kurts C, Oelke M, Schneck JP (2012) Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res 72:3744\u20133752. doi:10.1158\/0008-5472.CAN-11-2695","journal-title":"Cancer Res"},{"key":"1920_CR41","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/jnci\/81.19.1489","volume":"81","author":"BA Sela","year":"1989","unstructured":"Sela BA, Iliopoulos D, Guerry D, Herlyn D, Koprowski H (1989) Levels of disialogangliosides in sera of melanoma patients monitored by sensitive thin-layer chromatography and immunostaining. J Natl Cancer Inst 81:1489\u20131492","journal-title":"J Natl Cancer Inst"},{"key":"1920_CR42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10495-015-1103-7","volume":"20","author":"I Horwacik","year":"2015","unstructured":"Horwacik I, Rokita H (2015) Targeting of tumor-associated gangliosides with antibodies affects signaling pathways and leads to cell death including apoptosis. Apoptosis 20:679\u2013688. doi:10.1007\/s10495","journal-title":"Apoptosis"},{"key":"1920_CR43","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/eji.200323693","volume":"33","author":"G Nicoll","year":"2003","unstructured":"Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker PR (2003) Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and \u2013independent mechanisms. Eur J Immunol 33:1642\u20131648","journal-title":"Eur J Immunol"},{"key":"1920_CR44","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.4049\/jimmunol.171.10.5140","volume":"171","author":"IF Hermans","year":"2003","unstructured":"Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V (2003) NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171:5140\u20135147","journal-title":"J Immunol"},{"key":"1920_CR45","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3892\/ijmm.2011.631","volume":"27","author":"NC Mackenzie","year":"2011","unstructured":"Mackenzie NC, Zhu D, Longley L, Patterson CS, Kommareddy S, MacRae VE (2011) MOVAS-1 cell line: a new in vitro model of vascular calcification. Int J Mol Med 27:663\u2013668. doi:10.3892\/ijmm.2011.631","journal-title":"Int J Mol Med"},{"key":"1920_CR46","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/eji.201545685","volume":"45","author":"BE Clausen","year":"2015","unstructured":"Clausen BE, Brand A, Karram K (2015) Surmounting limited gene delivery into primary immune cell populations: efficient cell-type-specific adenoviral transduction by CAR. Eur J Immunol 45:1596\u20131599. doi:10.1002\/eji.201545685","journal-title":"Eur J Immunol"},{"key":"1920_CR47","first-page":"771","volume":"14","author":"Y Wan","year":"1999","unstructured":"Wan Y, Emtage P, Foley R, Carter R, Gauldie J (1999) Murine dendritic cells transduced with an adenoviral vector expressing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression. Int J Oncol 14:771\u2013776","journal-title":"Int J Oncol"},{"key":"1920_CR48","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/cei.12447","volume":"179","author":"Q Chen","year":"2015","unstructured":"Chen Q, Ross AC (2015) \u0391-Galactosylceramide stimulates splenic lymphocyte proliferation in vitro and increases antibody production in vivo in late neonatal-age mice. Clin Exp Immunol 179:188\u2013196. doi:10.1111\/cei.12447","journal-title":"Clin Exp Immunol"},{"key":"1920_CR49","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.4049\/jimmunol.1400769","volume":"193","author":"L Zhang","year":"2014","unstructured":"Zhang L, Tschumi BO, Corgnac S, Ruegg MA, Hall MN, Mach JP, Romero P, Donda A (2014) Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function. J Immunol 193:1759\u20131765. doi:10.4049\/jimmunol.1400769","journal-title":"J Immunol"},{"key":"1920_CR50","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.4049\/jimmunol.178.5.2853","volume":"178","author":"K Shimizu","year":"2007","unstructured":"Shimizu K, Goto A, Fukui M, Taniguchi M, Fujii S (2007) Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resitance to tumor implantation in mice. J Immunol 178:2853\u20132861","journal-title":"J Immunol"},{"key":"1920_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.20030446","volume":"198","author":"DY Wu","year":"2003","unstructured":"Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB (2003) Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 198:173\u2013181","journal-title":"J Exp Med"},{"key":"1920_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1517\/14728214.8.1.27","volume":"8","author":"G Ada","year":"2003","unstructured":"Ada G, Ramshaw I (2003) DNA vaccination. Expert Opin Emerg Drugs 8:27\u201335","journal-title":"Expert Opin Emerg Drugs"},{"key":"1920_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00262-010-0932-z","volume":"60","author":"M Kurosaki","year":"2011","unstructured":"Kurosaki M, Horiguchi S, Yamasaki K, Uchida Y, Motohashi S, Nakayama T, Sugimoto A, Okamoto Y (2011) Migration and immunological reaction after the administration of \u03b1GalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer. Cancer Immunol Immunother 60:207\u2013215. doi:10.1007\/s00262-010-0932-z","journal-title":"Cancer Immunol Immunother"},{"key":"1920_CR54","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1038\/emboj.2012.87","volume":"31","author":"P Barral","year":"2012","unstructured":"Barral P, Sanchez-Nino MD, van Rooijen N, Cerundolo V, Batista FD (2012) The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J 31:2378\u20132390. doi:10.1038\/emboj.2012.87","journal-title":"EMBO J"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1920-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-016-1920-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1920-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:15:22Z","timestamp":1744071322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-016-1920-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,27]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1920"],"URL":"https:\/\/doi.org\/10.1007\/s00262-016-1920-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,27]]},"assertion":[{"value":"27 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}